A team is developing a ‘bionic eye’ using highly advanced imaging technology to distinguish between healthy and diseased brain tissue.
Researchers hope this innovative solution will offer higher levels of precision to neurosurgeons in removing tumour tissue and, at the same time, protect healthy brain tissue.
AI technology currently being developed by the Brain Tumour Research Centre of Excellence at Imperial College London in collaboration with the team at the Hamlyn Centre, one of the Institute of Global Health Innovation’s research centres at Imperial College London, could transform neurosurgery.